Pharmaceutical Sources

Latest News for: Pharmaceutical sources

Edit

ROTH Capital Partners to Host ROTH Battle of the NASH Thrones Spring Investor Conference in ...

The Marshall News Messenger 21 Mar 2019

(Source ... Intercept Pharmaceuticals, Enanta Pharmaceuticals, Metacrine ... CymaBay Therapeutics, Madrigal Pharmaceuticals, Perspectum Diagnostics and American Liver Foundation ... Conatus Pharmaceuticals, Inc ... ContraVir Pharmaceuticals, Inc ... Enanta Pharmaceuticals, Inc ... Galmed Pharmaceuticals, Inc ... Intercept Pharmaceuticals, Inc ... Madrigal Pharmaceuticals, Inc....

Edit

Internet Marketing Agency, fishbat, Offers 4 Tips for Pharmaceutical Companies to Build and Maintain Their Customer Service Through Social Media

Market Watch 21 Mar 2019

PATCHOGUE, N.Y., March 21, 2019 /PRNewswire/ -- As part of their ongoing efforts to teach companies how to self-promote across social channels, fishbat, an internet marketing agency, shares four tips for pharmaceutical companies to build and maintain their customer service through social media ... SOURCE fishbat....

Edit

Mirum Pharmaceuticals Appoints Chris Peetz as Chief Executive Officer

Pharmiweb 21 Mar 2019

FOSTER CITY, Calif., March 21, 2019 /PRNewswire/ -- Mirum Pharmaceuticals today announced the appointment of Chris Peetz as chief executive officer ... Prior to Tobira, Chris held business leadership roles at Jennerex Biotherapeutics, Onyx Pharmaceuticals and Abgenix ... About Mirum Pharmaceuticals. Mirum Pharmaceuticals Inc ... SOURCE Mirum Pharmaceuticals....

Edit

Innovus Pharmaceuticals Reports Preliminary Annual 2018 Net Revenue of $24 Million

Market Watch 21 Mar 2019

Innovus Pharmaceuticals, Inc ... About Innovus Pharmaceuticals, Inc. Headquartered in San Diego, Innovus Pharma is an emerging OTC consumer goods and specialty pharmaceutical company engaged in the ... View source version on businesswire.com ... SOURCE. Innovus Pharmaceuticals, Inc....

Edit

Lexaria Bioscience Corp.: Altria's Other Investment

Seeking Alpha 21 Mar 2019

Background. In one of my recent articles Altria ... (OTCQX.LXRP) further ... (Source ... The Technology. LXRP is a pharmaceutical company at its core and operates out of Kelowna, British Columbia, in Canada ... 0 (Source ... Source ... Pharmaceuticals - Lexaria Pharmaceutical Corp HempCo - The Lexaria Hemp Co ... (Source ... - (Source ... The Outlook ... - (Source ... (Source ... Source ... - (Source....

Edit

Sprout Pharmaceuticals Presents Important New Addyi Safety and Tolerability Data through Three Alcohol Interaction Studies ...

The Record 21 Mar 2019

LOS ANGELES, March 21, 2019 /PRNewswire/ -- Sprout Pharmaceuticals, Inc ... said Cindy Eckert, Founder and CEO of Sprout Pharmaceuticals ... ABOUT SPROUT PHARMACEUTICALS Sprout Pharmaceuticals, Inc ... With the FDA, Sprout Pharmaceuticals developed a ... SOURCE Sprout Pharmaceuticals, Inc....

Edit

Sprout Pharmaceuticals Presents Important New Addyi Safety and Tolerability Data through Three Alcohol Interaction Studies in Which There Was No Syncope or Orthostatic Hypotension Requiring Medical Attention and No Increase in Adverse Events of Special Interest

Pharmiweb 21 Mar 2019

LOS ANGELES, March 21, 2019 /PRNewswire/ -- Sprout Pharmaceuticals, Inc ... said Cindy Eckert, Founder and CEO of Sprout Pharmaceuticals ... ABOUT SPROUT PHARMACEUTICALS. Sprout Pharmaceuticals, Inc ... With the FDA, Sprout Pharmaceuticals developed a ... SOURCE Sprout Pharmaceuticals, Inc....

Edit

Aerie Pharmaceuticals Initiates Netarsudil Ophthalmic Solution Phase 2 Clinical Trial in Japan Designed to Support Requirements for Future Regulatory Filing

Market Watch 21 Mar 2019

Aerie Pharmaceuticals, Inc ... About Aerie Pharmaceuticals, Inc. Aerie is an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye ... View source version on businesswire.com ... SOURCE....

Edit

Abzena Announces New Fully Integrated Developability and Optimization Service to Improve Lead Selection and De-risk ...

The Galveston Daily News 21 Mar 2019

Abzena provides the most complete set of solutions in integrated early discovery to mid-phase biotherapeutic and ADC drug development services in the pharmaceutical industry ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20190321005425/en/ ... HEALTH BIOTECHNOLOGY CLINICAL TRIALS PHARMACEUTICAL RESEARCH SCIENCE. SOURCE....

Edit

Last Participant out in USA Phase 2 Clinical Trial of BiondVax's M-001 Universal Influenza Vaccine Candidate

Pharmiweb 21 Mar 2019

JERUSALEM, March 21, 2019 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd ... Louis, Missouri) and at BiondVax Pharmaceuticals ... that could cause the results to differ materially from those expected by the management of BiondVax Pharmaceuticals Ltd ... SOURCE BiondVax Pharmaceuticals Ltd....

Edit

Customers’ experience leads to a highly successful outcome for Vetter at the 2019 CMO Leadership Awards

Finger Lakes Times 21 Mar 2019

Picture source ... Currently employing 4,500 individuals worldwide, the company has long-term experience in supporting biotechnology and pharmaceutical customers both large and small ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20190321005460/en/ ... SOURCE....

Edit

CStone receives approval in China to initiate Phase 1 clinical trial for RET inhibitor BLU-667 (CS3009)

Pharmiweb 21 Mar 2019

SUZHOU, China, March 21, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone"; HKEX ... Trial objectives include overall clinical response, duration of response, pharmacokinetics, pharmacodynamics and safety ... Frank Jiang ... The U.S ... CStone Pharmaceuticals (HKEX ... For more information about CStone Pharmaceuticals, please visit ... SOURCE CStone Pharmaceuticals. ....

Edit

Investment in Midwest Healthcare Companies Remains Steady at $2.5 Billion in 2018, Validating Record Increase ...

The Oneida Daily Dispatch 21 Mar 2019

These were the findings of the 2018 Midwest Healthcare Growth Capital Report, published annually by BioEnterprise, which tracks capital investments made in biomedical companies across 11 Midwestern states in three sectors – medical device; biotechnology and pharmaceuticals; and health IT/software and services ... SOURCE....